In 2013, Congress passed the Drug Supply Chain Security Act (DSCSA) to protect US citizens from counterfeit and harmful prescription drugs. The act outlines the need for manufacturers, repackagers, wholesalers, and dispensers to architect an electronic and interoperable system to track and trace prescription drugs.
We know this is a challenging time for many life science companies in feeling confident they are fully ready and aware of all guidance and standards, but it doesn’t have to be. Our DSCSA readiness assessment evaluates supply chain and track trace programs to identify any gaps in order to ensure readiness for FDA DSCSA deadlines.